Regencell Bioscience Holdings Ltd
RGC
查看詳細走勢圖
27.230USD
+2.160+8.62%
收盤 02/06, 16:00（美東）報價延遲15分鐘
13.46B總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+8.62%
5天
+8.96%
1月
-34.26%
6月
+94.92%
今年開始到現在
+29.67%
1年
+26083.70%
查看詳細走勢圖
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
Regencell Bioscience Holdings Ltd新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Regencell Bioscience Holdings Ltd簡介
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
公司代碼RGC
公司Regencell Bioscience Holdings Ltd
CEO
網址https://www.regencellbioscience.com/
相關品種
+3.63%
+3.17%
+0.93%
+1.99%
+1.78%
+1.53%
-0.96%
+4.49%
+2.10%
+10.00%
+2.72%
+4.07%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%熱門品種
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
71277.560
+472.390 (+0.67%)
282.580
+22.390 (+8.61%)
2097.750
-4.340 (-0.21%)
411.110
+13.900 (+3.50%)
5015.550
+62.570 (+1.26%)
62.812
-0.491 (-0.78%)
1.182
-0.000 (-0.03%)
156.867
-0.231 (-0.15%)
